Literature DB >> 10997984

Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease.

P Nurden1, F Chretien, C Poujol, J Winckler, A Borel-Derlon, A Nurden.   

Abstract

Several reports have described the presence of giant platelets in patients with type 2B von Willebrand disease (VWD). We have now characterized the ultrastructural changes in platelets from three unrelated patients with type 2B VWD and different mutations within exon 28 of the von Willebrand factor (VWF) gene. Electron microscopy showed that each of these subjects had an increased proportion of large platelets when compared with those of a patient with type 2A VWD or control subjects. Immunogold labelling for VWF was performed. Large masses detected by anti-VWF antibody were seen not only on the platelet surface, but also inside the platelet surface-connected canalicular system (SCCS) when ultrathin sections were labelled. This suggested translocation of the abnormally bound VWF from the platelet surface. Labelling of the alpha-granules was eccentric as for normal platelets. Labelling for glycoprotein (GP) Ib was seen on the surface and within the SCCS, suggesting co-localization with the bound VWF. However, there was no evidence for VWF in endosomes or other endocytic vesicles. The presence of platelet-bound VWF was not accompanied by high levels of platelet activation, as detected by electron microscopy, or by using monoclonal antibodies against P-selectin or activation-dependent determinants on GP IIb-IIIa in flow cytometry. Intriguingly, platelet ultrastructure often resembled that seen in patients with congenital thrombocytopathies characteristic of giant platelet syndromes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997984     DOI: 10.1046/j.1365-2141.2000.02246.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene.

Authors:  Paquita Nurden; Alan T Nurden; Silvia La Marca; Margherita Punzo; Luciano Baronciani; Augusto B Federici
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

3.  Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.

Authors:  William B Slayton; Milin Patel; Martha Sola-Visner; Neil Harris; Angela Rivers; Robert R Montgomery; Kenneth D Friedman
Journal:  J Pediatr Hematol Oncol       Date:  2008-09       Impact factor: 1.289

Review 4.  Of von Willebrand factor and platelets.

Authors:  Marijke Bryckaert; Jean-Philippe Rosa; Cécile V Denis; Peter J Lenting
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

5.  MicroRNAs 10a and 10b Regulate the Expression of Human Platelet Glycoprotein Ibα for Normal Megakaryopoiesis.

Authors:  Zuping Zhang; Yali Ran; Tanner S Shaw; Yuandong Peng
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

6.  2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines.

Authors:  Maha Othman; Emmanuel J Favaloro
Journal:  Res Pract Thromb Haemost       Date:  2021-12-20

7.  Quantitative 3D microscopy highlights altered von Willebrand factor α-granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms.

Authors:  Maurice Swinkels; Ferdows Atiq; Petra E Bürgisser; Johan A Slotman; Adriaan B Houtsmuller; Cilia de Heus; Judith Klumperman; Frank W G Leebeek; Jan Voorberg; Arend Jan Gerard Jansen; Ruben Bierings
Journal:  Res Pract Thromb Haemost       Date:  2021-09-14

8.  Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.

Authors:  Eliane Berrou; Alexandre Kauskot; Frédéric Adam; Amélie Harel; Paulette Legendre; Cécile Lavenu Bombled; Chantal Rothschild; Nicolas Prevost; Olivier D Christophe; Peter J Lenting; Cécile V Denis; Jean-Philippe Rosa; Marijke Bryckaert
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.